文献速递主动脉外科

术前双联抗血小板治疗增加A型急性主动脉夹层修复术出血与输血但不增加死亡率

Preoperative dual antiplatelet therapy increases bleeding and transfusions but not mortality in acute aortic dissection type A repair.
PubMed 文献 · Eur J Cardiothorac Surg · 2019-01-01

基于NORCAAD回顾性多中心数据库,1141例A型急性主动脉夹层患者中119例(10.4%)术前接受双联抗血小板治疗(DAPT)。倾向评分匹配后,DAPT组大出血仍显著更常见(51.3% vs 39.3%,OR 1.63,95%CI 1.05-2.51,P=0.028),但30天死亡率无显著差异(OR 0.88,95%CI 0.51-1.50,P=0.63);大出血本身与30天死亡率升高相关(校正OR 2.44,95%CI 1.72-3.46,P<0.0001)。

要点

  • 术前DAPT增加A型夹层修复术大出血和输血需求,但不增加30天死亡率。
  • 大出血本身与30天死亡率显著升高独立相关。
  • 正确诊断避免误用DAPT可降低出血风险,但不应因此延迟手术。

核心结论

  • A型急性主动脉夹层修复术前DAPT与大出血和输血增加相关,但与死亡率无显著相关。
  • 大出血本身与30天死亡率显著升高相关。

研究设计与样本

  • NORCAAD回顾性多中心数据库研究,1141例患者中119例(10.4%)术前接受DAPT,方案为ASA+氯吡格雷(n=108)或ASA+替格瑞洛(n=11)。
  • 采用逻辑回归模型在倾向评分匹配前后比较DAPT与非DAPT患者的大出血发生率和30天死亡率。

主要发现

  • 匹配前DAPT组大出血51.3% vs 非DAPT组37.7%(P=0.0049)。
  • DAPT组红细胞输注中位数8 U(Q1-Q3 4-15)vs 5.5 U(2-11),P<0.0001;血小板输注4 U(2-8)vs 2 U(1-4),P=0.0001。
  • 粗30天死亡率19.3% vs 17.0%(P=0.60)。
  • 匹配后大出血仍显著更常见:51.3% vs 39.3%(OR 1.63,95%CI 1.05-2.51;P=0.028),死亡率无显著差异(OR 0.88,95%CI 0.51-1.50;P=0.63)。
  • 大出血与30天死亡率升高相关(校正OR 2.44,95%CI 1.72-3.46;P<0.0001)。

临床怎么用

  • 正确诊断以避免误诊为急性冠脉综合征而启用DAPT,从而降低出血风险。
  • 正在接受DAPT的患者不应因此延迟急诊手术。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Acute aortic dissection type A is a life-threatening condition, warranting immediate surgery. Presentation with sudden chest pain confers a risk of misdiagnosis as acute coronary syndrome resulting in subsequent potent antiplatelet treatment. We investigated the impact of dual antiplatelet therapy (DAPT) on bleeding and mortality using the Nordic Consortium for Acute Type A Aortic Dissection (NORCAAD) database. METHODS: The NORCAAD database is a retrospective multicentre database where 119 of 1141 patients (10.4%) had DAPT with ASA + clopidogrel (n = 108) or ASA + ticagrelor (n = 11) before surgery. The incidence of major bleeding and 30-day mortality was compared between DAPT and non-DAPT patients with logistic regression models before and after propensity score matching. RESULTS: Before matching, 51.3% of DAPT patients had major bleeding when compared to 37.7% of non-DAPT patients (P = 0.0049). DAPT patients received more transfusions of red blood cells [median 8 U (Q1-Q3 4-15) vs 5.5 U (2-11), P < 0.0001] and platelets [4 U (2-8) vs 2 U (1-4), P = 0.0001]. Crude 30-day mortality was 19.3% vs 17.0% (P = 0.60). After matching, major bleeding remained significantly more common in DAPT patients, 51.3% vs 39.3% [odds ratio (OR) 1.63, 95% confidence interval (CI) 1.05-2.51; P = 0.028], but mortality did not significantly differ (OR 0.88, 95% CI 0.51-1.50; P = 0.63). Major bleeding was associated with increased 30-day mortality (adjusted OR 2.44, 95% CI 1.72-3.46; P < 0.0001). CONCLUSIONS: DAPT prior to acute aortic dissection repair was associated with increased bleeding and transfusions but not with mortality. Major bleeding per se was associated with a significantly increased mortality. Correct diagnosis is important to avoid DAPT and thereby reduce bleeding risk, but ongoing DAPT should not delay surgery.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Hansson EC, Geirsson A, Hjortdal V, et al. Preoperative dual antiplatelet therapy increases bleeding and transfusions but not mortality in acute aortic dissection type A repair. Eur J Cardiothorac Surg. 2019. PMID: 30657880. doi:10.1093/ejcts/ezy469

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。